Abstract
Bronchiectasis remains common in indigenous populations as reported from Alaska, Australia and New Zealand. Each of these countries has published incidence and prevalence estimates, suggested aetiologies, clinical course and associated factors which may contribute to the burden of disease. The purpose of this collaborative review is to summarise literature on bronchiectasis in indigenous peoples, discuss similarities and differences between these groups and countries, and compare these findings to recent reports on non-indigenous populations. Difficulties in applying best management practice are highlighted, including the difficult and confusing terminology, and suggestions made to address the unmet healthcare needs in order to reduce future respiratory morbidity and mortality in these populations.
Keywords: Indigenous, bronchiectasis, chronic cough, pneumonia, poverty, children, chronic respiratory disease
Current Pediatric Reviews
Title: Burden of Bronchiectasis in Indigenous Peoples - How Can it be Improved?
Volume: 5 Issue: 4
Author(s): Karen Munro, Rosalyn J. Singleton, Elizabeth A. Edwards, Gregory J. Redding, Anne B. Chang and Catherine A. Byrnes
Affiliation:
Keywords: Indigenous, bronchiectasis, chronic cough, pneumonia, poverty, children, chronic respiratory disease
Abstract: Bronchiectasis remains common in indigenous populations as reported from Alaska, Australia and New Zealand. Each of these countries has published incidence and prevalence estimates, suggested aetiologies, clinical course and associated factors which may contribute to the burden of disease. The purpose of this collaborative review is to summarise literature on bronchiectasis in indigenous peoples, discuss similarities and differences between these groups and countries, and compare these findings to recent reports on non-indigenous populations. Difficulties in applying best management practice are highlighted, including the difficult and confusing terminology, and suggestions made to address the unmet healthcare needs in order to reduce future respiratory morbidity and mortality in these populations.
Export Options
About this article
Cite this article as:
Munro Karen, J. Singleton Rosalyn, A. Edwards Elizabeth, J. Redding Gregory, B. Chang Anne and A. Byrnes Catherine, Burden of Bronchiectasis in Indigenous Peoples - How Can it be Improved?, Current Pediatric Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339609791317342
DOI https://dx.doi.org/10.2174/157339609791317342 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nitric Oxide in Allergic Rhinitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Principles and Therapeutic Relevance for Targeting Mitochondria in Aging and Neurodegenerative Diseases
Current Pharmaceutical Design Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
Current Pharmaceutical Design Improving Adherence to Antipsychotic Pharmacotherapy
Current Clinical Pharmacology Current Status of Antipsychotic Treatment
Current Drug Targets - CNS & Neurological Disorders The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review
Protein & Peptide Letters Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry The Use of Bifunctional NOP/Mu and NOP Receptor Selective Compounds for the Treatment of Pain, Drug Abuse, and Psychiatric Disorders
Current Pharmaceutical Design Breath Analysis: The Approach Towards Clinical Applications
Mini-Reviews in Medicinal Chemistry The α2δ Subunit and Absence Epilepsy: Beyond Calcium Channels?
Current Neuropharmacology <i>In-silico</i> Prediction of the Beta-carboline Alkaloids Harmine and Harmaline as Potent Drug Candidates for the Treatment of Parkinson’s disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry <i>Withania somnifera</i> in Neurological Disorders: Ethnopharmacological Evidence, Mechanism of Action and its Progress in Delivery Systems
Current Drug Metabolism Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Rehabilitation of Schizophrenic Patients
Current Pharmaceutical Design Pharmacotherapy of Schizophrenia: The Past, Present and Future
Current Drug Therapy Update on the Adverse Effects of Clozapine: Focus on Myocarditis
Current Drug Safety Neuropeptide Systems and Schizophrenia
CNS & Neurological Disorders - Drug Targets Novel Natural and Synthetic Ligands of the Endocannabinoid System
Current Medicinal Chemistry Is Nicotine Protective Against Parkinson´s Disease? An Experimental Analysis
CNS & Neurological Disorders - Drug Targets Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Current Neuropharmacology